Analyze Diet
Journal of veterinary internal medicine2024; 38(5); 2783-2789; doi: 10.1111/jvim.17164

Intravenous administration of quinidine and metoprolol for treatment of atrial fibrillation in 2 neonatal foals.

Abstract: Atrial fibrillation (AF) is a rarely reported arrhythmia in otherwise healthy newborn foals, with a single case of cardioversion using procainamide administration described in the literature. Two neonatal Thoroughbred colts were presented to an equine hospital because of an irregularly irregular tachyarrhythmia and poor latching when trying to nurse. History, physical examination, and initial diagnostic testing including ECG and echocardiography confirmed AF without structural heart disease. The 1st foal converted into normal sinus rhythm after treatment with IV metoprolol and quinidine. The 2nd foal converted to normal sinus rhythm after a single IV dose of metoprolol, intended for rate control. Demeanor and nursing behavior improved markedly after conversion. The 2 foals had normal heart rates and sinus rhythm that persisted for 6 weeks until euthanasia in the 1st foal and for 2 years in the 2nd foal. Rate control and cardioversion should be considered as a treatment for persistent lone AF in neonatal foals.
Publication Date: 2024-08-30 PubMed ID: 39212330PubMed Central: PMC11423457DOI: 10.1111/jvim.17164Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Intravenous administration of metoprolol and quinidine was used successfully to treat atrial fibrillation in two newborn foals, leading to a restoration of normal heart rhythm and improved nursing behavior.

Background and Clinical Context

  • Atrial fibrillation (AF) is an uncommon heart rhythm disorder in newborn foals without underlying heart disease.
  • Only one previous case of AF cardioversion in a newborn foal using procainamide has been reported before this study.
  • The condition involves an irregular and rapid heart rhythm that affects the foals’ ability to nurse effectively.

Case Presentations

  • Two Thoroughbred colt foals presented with:
    • Irregularly irregular tachyarrhythmia detected on ECG (electrocardiogram).
    • Poor nursing behavior and difficulty latching onto the mare.
    • No evidence of structural heart disease on echocardiography.

Treatment Approaches Used

  • Foal 1:
    • Received intravenous (IV) metoprolol followed by IV quinidine administration.
    • This combination successfully restored normal sinus rhythm (cardioversion).
  • Foal 2:
    • Received a single IV dose of metoprolol intended to control heart rate (rate control).
    • This led to cardioversion to sinus rhythm, even though quinidine was not administered.

Outcomes and Follow-Up

  • Both foals showed marked improvement in demeanour and nursing ability after the restoration of normal heart rhythm.
  • Heart rates normalized with persistence of sinus rhythm:
    • Foal 1 maintained sinus rhythm for six weeks until euthanasia due to unrelated reasons.
    • Foal 2 maintained sinus rhythm for two years, demonstrating long-term efficacy.

Clinical Significance and Recommendations

  • This study provides evidence that rate control and cardioversion are viable treatment options for persistent lone atrial fibrillation in neonatal foals without structural heart disease.
  • Intravenous administration of metoprolol, alone or combined with quinidine, can successfully restore normal sinus rhythm in affected foals.
  • These treatments can improve clinical signs such as poor nursing, which can improve survival and quality of life.

Cite This Article

APA
Leduc L, Abraham M, Slack J. (2024). Intravenous administration of quinidine and metoprolol for treatment of atrial fibrillation in 2 neonatal foals. J Vet Intern Med, 38(5), 2783-2789. https://doi.org/10.1111/jvim.17164

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 38
Issue: 5
Pages: 2783-2789

Researcher Affiliations

Leduc, Laurence
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
Abraham, Michelle
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
Slack, JoAnn
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / drug therapy
  • Animals, Newborn
  • Anti-Arrhythmia Agents / therapeutic use
  • Anti-Arrhythmia Agents / administration & dosage
  • Quinidine / therapeutic use
  • Quinidine / administration & dosage
  • Atrial Fibrillation / veterinary
  • Atrial Fibrillation / drug therapy
  • Metoprolol / therapeutic use
  • Metoprolol / administration & dosage
  • Male
  • Female
  • Electrocardiography / veterinary
  • Administration, Intravenous / veterinary

Conflict of Interest Statement

Authors declare no conflict of interest.

References

This article includes 17 references
  1. Yamamoto K, Yasuda J, Too K. Arrhythmias in newborn Thoroughbred foals. Equine Vet J 1992;24(3):169‐173.
    pubmed: 1606928
  2. Li H, Wei X, Zheng F, Wen J, Sun G. Atrial fibrillation in preterm neonates: a case study. J Electrocardiol 2021;65:66‐68.
    pubmed: 33549988
  3. Machida N, Yasuda J, Too K. Three cases of paroxysmal atrial fibrillation in the Thoroughbred newborn foal. Equine Vet J 1989;21(1):66‐68.
    pubmed: 2920703
  4. Alessi R, Nusynowitz M, Abildskov JA, Moe GK. Nonuniform distribution of vagal effects on the atrial refractory period. Am J Physiol 1958;194(2):406‐410.
    pubmed: 13559489
  5. Potter BM, Scansen BA, Dunbar LK, Reed SM, Toribio RE. Transcutaneous direct current cardioversion in a foal with lone atrial fibrillation. J Vet Cardiol 2017;19(1):99‐105.
    pubmed: 27815140
  6. Bassareo PP, Marras AR, Marras M, Marras S, Mercuro G. Atrial fibrillation in a preterm newborn with structurally normal heart. Oxf Med Case Reports 2017;2017(3):30‐32.
    pmc: PMC5509037pubmed: 28721223
  7. Ainger LE, Fitch CW, Lawyer NG. Atrial fibrillation in endocardial fibroelastosis: successful cardioversion with external countershock. Am J Dis Child 1966;111(6):655‐660.
  8. Linz D, Schotten U, Neuberger HR, Böhm M, Wirth K. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm 2011;8(9):1436‐1443.
    pubmed: 21457790
  9. Ataklte F, Erqou S, Laukkanen J, Kaptoge S. Meta‐analysis of ventricular premature complexes and their relation to cardiac mortality in general populations. Am J Cardiol 2013;112(8):1263‐1270.
    pubmed: 23927786
  10. Singer DH, Ten Eick RE. Aberrancy: electrophysiologic aspects. Am J Cardiol 1971;28(4):381‐401.
    pubmed: 4938003
  11. Berg MPVD, Ven LLMVD, Witting W. Effects of β‐blockade on atrial and atrioventricular nodal refractoriness, and atrial fibrillatory rate during atrial fibrillation in pigs. Jpn Heart J 1997;38(6):841‐848.
    pubmed: 9486937
  12. Lishmanov A, Chockalingam P, Senthilkumar A, Chockalingam A. Tachycardia‐induced cardiomyopathy: evaluation and therapeutic options. Congest Heart Fail Greenwich Conn 2010;16(3):122‐126.
    pubmed: 20557332
  13. Morris DD, Fregin GF. Atrial fibrillation in horses: factors associated with response to quinidine sulfate in 77 clinical cases. Cornell Vet 1982;72(4):339‐349.
    pubmed: 6754252
  14. Frye MA, Selders CG, Mama KR, Wagner AE, Bright JM. Use of biphasic electrical cardioversion for treatment of idiopathic atrial fibrillation in two horses. J Am Vet Med Assoc 2002;220(7):1039‐1045, 1007‐1045.
    pubmed: 12420784
  15. Im SI, Park DH, Kim BJ, Cho KI, Kim HS, Heo JH. Clinical and electrocardiographic characteristics for prediction of new‐onset atrial fibrillation in asymptomatic patients with atrial premature complexes. Int J Cardiol Heart Vasc 2018;19:70‐74.
    pmc: PMC5993103pubmed: 29892706
  16. Acharya T, Tringali S, Bhullar M, et al. Frequent atrial premature complexes and their association with risk of atrial fibrillation. Am J Cardiol. 2015;116(12):1852‐1857.
    pubmed: 26611122
  17. Thong T, McNames J, Aboy M, Goldstein B. Prediction of paroxysmal atrial fibrillation by analysis of atrial premature complexes. IEEE Trans Biomed Eng. 2004;51(4):561‐569.
    pubmed: 15072210

Citations

This article has been cited 1 times.
  1. Xu W, Li J, Ju J, Liu M, Wang W, Cheng M, Zhang X, Cui X, Chen H. The beta1-adrenergic receptor in the heart. Cell Death Discov 2025 Dec 10;12(1):46.
    doi: 10.1038/s41420-025-02907-wpubmed: 41372115google scholar: lookup